Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases. Established in 2016, Entrada Therapeutics is headquartered in Boston, Massachusetts, United States.
Last updated on
About Entrada Therapeutics
Founded
2016Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$391MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
541Location
City
BostonState
MassachusettsCountry
United StatesEntrada Therapeutics
Find your buyer within Entrada Therapeutics